Open Label Trial of INCB07839 to Determine Effect and Safety of INCB007839 Plus Trastuzumab in HER2 Positive Metastatic Breast Cancer
Clinical trial NCT00864175 · TERMINATED
Trial details
- NCT number
- NCT00864175
- Sponsor
- Incyte Corporation
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2007-07-01
- Primary completion
- 2011-06-01
- Enrollment
- 68
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.